Immunogenicity of Vi capsular polysaccharide vaccine evaluated for three years in Korea.

The immunogenicity of a single dose of Salmonella typhi(S.typhi) Vi capsular polysaccharide(CPS) vaccine was evaluated before, and at 1, 3, 12, and 36 months after vaccination. Eighty-five adults(20-28 years of age) and sixty-four children(8-16 years of age) received a single dose of 25 micrograms V...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Y. R., Yoo, J. H., Hur, J. K., Kang, J. H., Shin, W. S., Kang, M. W.
Formato: Texto
Lenguaje:English
Publicado: Korean Academy of Medical Sciences 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054155/
https://www.ncbi.nlm.nih.gov/pubmed/8750055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054155/
https://www.ncbi.nlm.nih.gov/pubmed/8750055

Ejemplares similares